OneRobotics (Shenzhen) Co., Ltd. (abbreviated “ONEROBOTICS”) released its 2026 interim report, highlighting rapid top-line expansion but a swing to loss driven by foreign-exchange pressure and heavier research spending.

Financial Performance • Revenue rose 31.8% year on year to RMB 522.39 million, supported by the rollout of new products including the humanoid home robot H1, Acemate AI sports robot and KATA Friends companion robot. • Gross profit increased 22.5% to RMB 263.12 million; gross margin narrowed to 50.4% from 54.2% due to yen and U.S.-dollar weakness against the renminbi. • R&D expenses surged 73.3% to RMB 101.72 million, lifting the R&D ratio to 19.5% of revenue (1H 2025: 14.8%). • Net foreign-exchange loss reached RMB 42.70 million; forward FX contracts generated RMB 33.80 million of gains, partly offsetting currency effects. • The Group reported a net loss of RMB 38.29 million versus a profit of RMB 27.90 million a year earlier.

Segment Highlights • Home embodied AI robotic system products contributed RMB 453.46 million (86.8% of revenue), up 30.0%. New product lines added RMB 68.40 million. • Other smart-home and emerging AI products & solutions posted RMB 68.93 million, rising 45.3%.

Geographic Mix • Europe and North America led growth, with revenues up 97.5% and 85.7% respectively. Combined share of total sales expanded to 42.1% (1H 2025: 28.8%). • Asia generated 57.4% of revenue, up 6.6% year on year.

Balance Sheet & Liquidity • Cash and bank balances stood at RMB 1.48 billion, down RMB 122.52 million from end-2025, mainly due to working-capital build-up, strategic investments and share-award purchases. • Interest-bearing bank loans increased to RMB 335.09 million; debt-to-equity ratio rose to 24.9% (31 Dec 2025: 14.0%). • Net operating cash outflow reached RMB 164.66 million, compared with a RMB 29.17 million inflow in the prior-year period.

Use of IPO Proceeds • Of the HK$1.77 billion raised in the December 2025 Hong Kong listing, HK$545.53 million has been deployed, primarily for R&D and sales-channel expansion. HK$1.22 billion remains unutilized.

Strategic Investments • Acquired a 21% stake in Hitbot Technology (Shenzhen) Co., Ltd. for RMB 240.56 million to strengthen end-effector capabilities. • Agreed to purchase up to US$40.54 million of shares in Nanoleaf Limited; post-period, 9.02 million shares were acquired for US$13.53 million to accelerate overseas channel development.

Operational Developments • Launched OneModel 1.7 FrontoStria-RL, cementing the “One Brain, Multiple Embodiments” strategy and enabling real-world learning loops across humanoid and other robotic platforms. • Secured a RMB 44.95 million embodied-AI data-infrastructure contract in Shenzhen, with partial delivery completed. • H1 humanoid robot entered commercial delivery; partnership formed with 58.com for local service scenarios. • Acemate deployed in over 1,100 tennis courts and named official training robot for the 2026 China Open. • KATA Friends companion robot rolled out in Japan, China and Europe, with pilot collaboration at Shanghai Children’s Medical Center.

Outlook Management will focus on broadening product deployment, enhancing model generalization across home tasks, scaling data-infrastructure operations and deepening the “Embodied Intelligence Chain” through further investments and global channel expansion.